Literature DB >> 23892904

Correlation of radiation treatment interruptions with psychiatric disease and performance status in head and neck cancer patients.

Radhika Sreeraman1, Srinivasan Vijayakumar, Allen M Chen.   

Abstract

PURPOSE: The purpose of this study is to identify factors predictive of treatment interruptions during radiation therapy (RT) for head and neck cancer. METHODS AND MATERIALS: The medical records of 280 consecutive patients who completed a 6- or 7-week course of RT for squamous cell carcinoma of the head and neck were reviewed. The number of missed treatment days, excluding those due to holidays or machine downtime, was determined for each patient. All patients were treated to a median dose of 63 Gy (range, 60 to 70 Gy).
RESULTS: The proportion of patients who missed 0, 3-5, 6-10, and greater than 10 days was 25, 59, 12, and 5 %, respectively. The percentage of patients who missed greater than 5 days was 62 % among the 39 patients with Karnofsky Performance Status (KPS) score of 70 or less compared to 10 % among those with a KPS score of greater than 70 (p < 0.01). Among the 33 patients identified with a preexisting psychiatric condition, the percentage that subsequently missed greater than 5 days of treatment was 48 % compared to 13 % among those without a psychiatric condition. When missed RT days were analyzed as a continuous variable, the correlations with both KPS and preexisting psychiatric condition remained highly significant (p < 0.01, for both).
CONCLUSION: Poor performance status and preexisting psychiatric condition predicted for treatment interruptions during RT for head and neck cancer. In view of the possible detrimental effect on treatment outcome, appropriate social programs should be initiated to overcome potential barriers to RT for these particular populations.

Entities:  

Mesh:

Year:  2013        PMID: 23892904     DOI: 10.1007/s00520-013-1907-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  30 in total

1.  Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules.

Authors:  Patti A Groome; Brian O'Sullivan; William J Mackillop; Lynda D Jackson; Karleen Schulze; Jonathan C Irish; Padraig R Warde; Ken M Schneider; Robert G Mackenzie; D Ian Hodson; J Alex Hammond; Sunil P P Gulavita; Libni J Eapen; Peter F Dixon; Randy J Bissett
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-01-18       Impact factor: 7.038

2.  Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers.

Authors:  C Robertson; A G Robertson; J H Hendry; S A Roberts; N J Slevin; W B Duncan; R H MacDougall; G R Kerr; B O'Sullivan; T J Keane
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-15       Impact factor: 7.038

3.  Effect of radiotherapy interruptions on survival in medicare enrollees with local and regional head-and-neck cancer.

Authors:  Megan Dann Fesinmeyer; Vivek Mehta; David Blough; Lauri Tock; Scott D Ramsey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-03       Impact factor: 7.038

Review 4.  Cancer-related fatigue and sleep disorders.

Authors:  Joseph A Roscoe; Maralyn E Kaufman; Sara E Matteson-Rusby; Oxana G Palesh; Julie L Ryan; Sadhna Kohli; Michael L Perlis; Gary R Morrow
Journal:  Oncologist       Date:  2007

5.  Depression in radiation oncology patients: a preliminary evaluation.

Authors:  C Jenkins; T J Carmody; A J Rush
Journal:  J Affect Disord       Date:  1998-07       Impact factor: 4.839

6.  Screening for depression in head and neck cancer.

Authors:  Mark R Katz; Neil Kopek; John Waldron; Gerald M Devins; George Tomlinson
Journal:  Psychooncology       Date:  2004-04       Impact factor: 3.894

Review 7.  Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation.

Authors:  Nuran Senel Bese; Jolyon Hendry; Branislav Jeremic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-04-30       Impact factor: 7.038

8.  Quality of life scores predict survival among patients with head and neck cancer.

Authors:  Carrie A Karvonen-Gutierrez; David L Ronis; Karen E Fowler; Jeffrey E Terrell; Stephen B Gruber; Sonia A Duffy
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

9.  Association between depressive and anxiety disorders and adherence to antihypertensive medication in community-living elderly adults.

Authors:  Lia Gentil; Helen Maria Vasiliadis; Michel Préville; Cindy Bossé; Djamal Berbiche
Journal:  J Am Geriatr Soc       Date:  2012-10-30       Impact factor: 5.562

10.  The hazard of accelerated tumor clonogen repopulation during radiotherapy.

Authors:  H R Withers; J M Taylor; B Maciejewski
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089

View more
  4 in total

1.  The "rocky treatment course": identifying a high-risk subgroup of head and neck cancer patients for supportive interventions.

Authors:  Horia Vulpe; Janet Ellis; Shao Hui Huang; Eshetu G Atenafu; Raymond W Jang; Gary Rodin; Jolie Ringash
Journal:  Support Care Cancer       Date:  2016-11-04       Impact factor: 3.603

Review 2.  Psychosocial Issues in Patients with Head and Neck Cancer: an Updated Review with a Focus on Clinical Interventions.

Authors:  Joshua D Smith; Andrew G Shuman; Michelle B Riba
Journal:  Curr Psychiatry Rep       Date:  2017-09       Impact factor: 5.285

3.  Evaluation of the correlation between side effects to oral mucosa, salivary glands, and general health status with quality of life during intensity-modulated radiotherapy for head and neck cancer.

Authors:  Marina Kimie Oba; Lara Maria Alencar Ramos Innocentini; Gustavo Viani; Hilton Marcos Alves Ricz; Thiago de Carvalho Reis; Tatiane Cristina Ferrari; Leandro Dorigan de Macedo
Journal:  Support Care Cancer       Date:  2020-04-21       Impact factor: 3.603

4.  Impact of Performance Status and Comorbidity on Palliative Radiation Treatment Tolerance and End-Of-Life Decision-Making.

Authors:  Haley K Perlow; Vincent Cassidy; Benjamin Farnia; Deukwoo Kwon; Adam W Awerbuch; Stephanie Ciraula; Scott Alford; Jacob Griggs; Joseph A Quintana; Raphael Yechieli; Stuart E Samuels
Journal:  Adv Radiat Oncol       Date:  2018-09-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.